Recruiting studies: Haemophilia A With Inhibitors

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Pr
Phase 4 · 2 location(s) · Sanofi · NCT06145373 A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Phase 3 · 2 location(s) · Hoffmann-La Roche · NCT07416526 Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors
Phase N/A · 1 location(s) · Karolinska Institutet · NCT02453542 SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
Phase 3 · 2 location(s) · Emory University · NCT04563520 PCC Treatment for Hemophilia Patients With Inhibitor（2022PCC-A）
Phase 4 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07406139 Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients
Phase 3 · 18 location(s) · Jiangsu BioJeTay Biotechnology Co., Ltd. · NCT06922045 A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
Phase 3 · 152 location(s) · Novo Nordisk A/S · NCT05685238 Safety of KN057 Prophylaxis in Patients With Haemophilia A or B
Phase 3 · 1 location(s) · Suzhou Alphamab Co., Ltd. · NCT07545395 Treatment of Hemophilia A Patients With FVIII Inhibitors
Phase N/A · 2 location(s) · Emory University · NCT04023019 A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
Phase 1 · 7 location(s) · Pfizer · NCT06703606 SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Phase 4 · 21 location(s) · American Thrombosis and Hemostasis Network · NCT04647227 A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Phase 3 · 34 location(s) · Pfizer · NCT05611801 Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Phase 3 · 75 location(s) · Pfizer · NCT05145127

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.